Next Article in Journal
The Effects of Exercise Training on Glucose Homeostasis and Muscle Metabolism in Type 1 Diabetic Female Mice
Previous Article in Journal
Sinomenine Ameliorates Colitis-Associated Cancer by Modulating Lipid Metabolism via Enhancing CPT1A Expression
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells

1
Department of Biotechnology, Jamia Millia Islamia, New Delhi 110025, India
2
Bioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India
3
Department of Food Technology School of Interdisciplinary Science & Technology, Jamia Hamdard, New Delhi 110062, India
4
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
5
Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Metabolites 2022, 12(10), 947; https://doi.org/10.3390/metabo12100947
Submission received: 4 September 2022 / Revised: 28 September 2022 / Accepted: 29 September 2022 / Published: 5 October 2022
(This article belongs to the Section Plant Metabolism)

Abstract

:
Diabetes mellitus leads to cellular damage and causes apoptosis by oxidative stress. Heartwood extract of Pterocarpus marsupium has been used in Ayurveda to treat various diseases such as leprosy, diabetes, asthma, and bronchitis. In this study, we worked out the mechanism of the antidiabetic potential of methanolic heartwood extract of Pterocarpus marsupium (MPME). First, metabolic profiling of MPME was done using gas chromatography-mass spectrometry (GCMS), ultra-performance liquid chromatography-mass spectroscopy (UPLC-MS), and high-performance thin-layer chromatography (HPTLC) to identify phenols, flavonoids, and terpenoids in MPME. Biological studies were carried out in vitro using the HepG2 cell line. Many antidiabetic compounds were identified including Quercetin. Methanolic extract of MPME (23.43 µg/mL–93.75 µg/mL) was found to be safe and effective in reducing oxyradicals in HepG2 cells. A concentration of 93.75 µg/mL improved glucose uptake efficiently. A significant decrease in oxidative stress, cell damage, and apoptosis was found in MPME-treated HepG2 cells. The study suggests that the heartwood of Pterocarpus marsupium offers good defense in HepG2 cells against oxidative stress and improves glucose uptake. The results show the significant antidiabetic potential of MPME using a HepG2 cell model. The effect seems to occur by reducing oxidative stress and sensitizing the cells towards glucose uptake, hence lowering systemic glucose levels, as well as rescuing ROS generation.

1. Introduction

Diabetes mellitus (DM) is a term used to describe a group of metabolic abnormalities marked by persistent hyperglycemia. Type 2 diabetes mellitus (T2DM) is sometimes cited as non-insulin-dependent diabetes mellitus (NIDDM) as it occurs because of the inability of beta cells of the pancreas to secrete insulin, defects in insulin action, or both [1]. T2DM is linked to acute and chronic complications, which cause most DM-related fatalities, as well as financial strain and poor quality of life. Diabetes prevalence in the 20 to 79-year age group was estimated to be 463 million in 2019, and this number is anticipated to rise to 700 million by 2045 [2]. Diabetes alone is responsible for about 1 million deaths per year, making it the tenth-largest cause of human death [3]. Oxidative stress is significantly linked to diabetes mellitus (DM) [4]. Glucose-autooxidation and protein metabolism leads to excessive production of reactive oxygen species (ROS), and chronic hyperglycemia caused by diabetes increases oxidative stress and damages the structural elements of cells. It adversely affects nerves, blood vessels, and delicate organs, including the eyes and kidneys [5].
Patients with DM are more likely to develop significant complications such as dyslipidemia and cardiovascular disease, which are the leading causes of fatality. Diabetes has an impact on contagious diseases, and post-disease side effects, and can cause fatality from severe infections, increasing the risk of complications along with comorbidities in patients due to the coronavirus outburst (COVID-19), which has evolved into a global health crisis [6]. There is a need for proper medicine to counter diabetes. Antidiabetic drugs based on modern allopathy are time-consuming, need to be taken in multiple doses and are frequently taken by patients for the rest of their lives. For the treatment of diabetes, a variety of chemical hypoglycemic drugs such as metformin, acarbose are meglitinides are available. However, side effects such as increased cardiovascular risk, gastrointestinal problems, stomach discomfort, diarrhea, and hepatotoxicity have been linked to these synthetic medications [7]. As a result, natural products are in great demand for the treatment of diabetes and its complications because they have fewer side effects than synthetic drugs. The ability of phytochemicals to function as substitutes for allopathic medications used in diabetes treatment involves their strong antioxidant capability, which aids in battling oxidative stress as well as other cellular injuries, and provides new insight into treating diabetes mellitus [8]. Some medicinal plants are reported to regulate different pathways that control blood glucose and activate fatty acid oxidation linked to insulin resistance [9]. Medicinal herbs are precursors for producing valuable medications because of their safety, cheap cost, availability, and manageable side effects.
The deciduous tree Pterocarpus marsupium Roxb. (PM) is found in Sri Lanka and India. It is known in Hindi as Vijaysar and is a significant medicinal plant used as a folk medicine to treat diabetes. Because of its therapeutic and laxative effects, it is well-known in the Ayurvedic system of medicine. The heartwood of PM is used as a depurative, hemostatic, and rejuvenating agent, and is used to treat many life-threatening diseases such as diabetes, bronchitis, and leprosy [10]. The bark, seed, and heartwood of PM have been particularly beneficial in decreasing hyperglycemia in pharmacological trials [11]. Despite carrying a rich content of valuable phytochemicals, minimal attention has been paid to exploring the anti-diabetic properties of this plant. In this study, we studied the possible anti-diabetic mechanism of Pterocarpus marsupium. The outcome of the study may result in managing diabetes with fewer side effects at a low cost. In this study, we used an in vitro HepG2 cell model to evaluate the therapeutic potential of a methanolic heartwood extract of Pterocarpus marsupium (MPME).
To the best of our knowledge, there have been no reports on the antidiabetic effect of the heartwood of PM on HepG2 cells. The study shows the chemoprotective effect of heartwood extract of PM against ROS stimulated by high glucose stress in HepG2 cultured cells. High-throughput screening, cellular antioxidant potential, and glucose uptake potential were explored to provide specific insights into the mechanism of action of PM against type 2 diabetes mellitus.

2. Materials and Methods

Materials were acquired as follows: TLC silica gel 60F254 (Merck KGaA Darmstadt, Germany), Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum (FBS) (GIBCO, Waltham, MA, USA), 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT), trypsin, propidium iodide (Himedia, India), glucose uptake-assay-kit (Eton Bioscience, SKU-1200032002), acridine orange (Merck, Germany), ethidium bromide (Invitrogen, Waltham, MA, USA), 4′,6-diamidino-2-phenylindole (DAPI) (Thermo Fisher, Waltham, MA, USA), and antibiotic (penicillin-streptomycin) (CAISSON, Smithfield, UT, USA). Unless otherwise specified, all cell culture chemicals and standards were purchased from Sigma (St. Louis, MI, USA).

2.1. Collection of Plant Material

The selected plant material was procured and authenticated as per the standard protocol specified in the Ayurvedic Pharmacopeia of India. The authenticated plant material was deposited in the Bioactive Natural Product Laboratory for future reference with voucher no JH/BNPL/SA/2020/PM.

2.2. Preparation of Plant Extracts

Well-grown and healthy heartwood of Pterocarpus marsupium was rinsed with distilled water and dried in a hot-air oven at 40 °C. The dried plant part was ground into a fine powder, and 50 g of plant sample was extracted in 500 mL of methanol at ambient temperature for 5 h using a Soxhlet device. After cooling, the extract was filtered, and the filtrate was dried by incubation at 35–38 °C at reduced pressure. Further, the percentage yield of the obtained crude methanolic extract was calculated and then stored at 4 °C for further experiments.
%Yield of extract (g/100 g) = Weight of dried extract × 100/Weight of plant material

2.3. Physicochemical Analysis

The powdered sample was tested for physicochemical parameters including total ash, acid insoluble ash, and water-soluble ash, as well as moisture content, according to WHO guidelines on quality control methods for medicinal plant materials and standard methods prescribed in the Indian Pharmacopeia [12].

2.4. Estimation of Total Phenolic and Flavonoid Content

The Folin Ciocalteu method was employed to determine the total phenol content (TPC) of MPME [13]. Gallic acid was used as a standard. A UV spectrophotometer (iMark Microplate Reader Bio-Rad, Hercules, CA, USA) was used to measure optical density at 765 nm. The standard curve of gallic acid (10−1000 μg/mL) was used to derive the estimation of TFC of MPME and the content was expressed as mg gallic acid equivalent/gm of MPME (mg GAE/gm of MPME). The aluminum chloride colorimetric method was employed to determine the total flavonoid content (TFC) of the MPME [14] and read at 415 nm. TFC was calculated from a standard curve of rutin (10−1000 μg/mL), and the content was expressed as mg rutin equivalent/gm MPME (mg rutin/gm of MPME).

2.5. Phytochemical Profiling by GCMS

Precisely 500 μL of the sample was mixed with 500 μL of hexane into a centrifuge tube and then passed through a 0.25 μ polytetrafluoroethylene membrane filter. A 2 μL filtered sample was processed in a GC–MS (Agilent 7890A series, Agilent, Santa Clara, CA, USA) with CTC-PAL autosampler attached to HP-5MS (5% phenyl polydimethylsiloxane) capillary column (30 m × 0.25 mm I.D and 0.25 μm film thickness) and associated with a mass detector (Agilent 5975C inert XL EI/CI MSD with Triple-Axis Detector, Agilent Technology, Santa Clara, CA, USA). The temperature of the instrument was set at 50 °C for 5 min and was then elevated up to 280 °C at a specific rate of 10 °C/min, and for 7 min with a run time of 42 min. Mass spectra were reported from m/z 50 to 700 at 0.5 s/scan. The software installed within the instrument, Wiley and NIST (comparison software National Institute of Standards and Technology) library, was involved in the identification of phytoconstituents [15].

2.6. HPTLC Fingerprinting and Quantitative Analysis

In a stationary phase, an aluminum silica gel 60 F254 plates (20 × 10 cm, 0.2 mm thickness) was employed on which the sample and standard Quercetin were adsorbed using a CAMMAG Linomat V at a pace of 150 nL/s, and in the arrangement of bands (6.0 mm). The mobile phase for TLC development was made up of toluene, ethyl acetate, methanol, and formic acid (6:3:0.5:0.5, v/v/v/v). TLC was developed in a twin trough glass chamber after saturation of the mobile phase for 30 min at room temperature up to a length of 80 mm. After drying by an air-dryer, the TLC plate was scanned and digitized. Densitometric scanning was carried out on a CAMAG TLC Scanner 3 at absorbances of 254 nm and 366 nm. The concentration of Quercetin was measured quantitatively at 254 nm [16].

2.7. Ultraperformance Liquid Chromatography-Mass Spectroscopy (UPLC-MS) Studies

UPLC-MS analysis of MPME was performed using a Waters ACQUITY UPLC system (Serial No. #F09 UPB 920M; Model code # UPB; Waters Corp., Milford, MA, USA) equipped with a binary solvent delivery system, column manager, autosampler, and a tunable MS detector (Serial No # JAA 272; Synapt; Waters, Manchester, UK). MPME was chromatographically separated in gradient elution mode using a previously degassed mobile phase containing 0.3% v/v formic acid in water (A) and acetonitrile (B) (initially, 10% A; 0–5 min 40% A; 5–10 min 60% A; 10–13 min, 90% A; 13–15 min, 100% A, 15–16 min 10% A).The total run time was 16 min. The mobile phase flow rate was 0.4 mL/min and the column used was Water’s ACQUITYUPLCBEH C18 (100 2.1 mm 1.7 m). Precisely 10 µL of the sample was injected with the help of an auto-injector, in a split mode of 5:1, and the system pressure was set to 15,000 psi. The MS detector identified the separated metabolites. The UPLC and mass detector were both regulated by MassLynxV4.1 software installed with this instrument. A literature search was used to identify the separated compounds based on their m/z value [15].

2.8. Cell Culture and Treatments

The HepG2 cell line was gifted by Dr. Sayed Naqui Kazim Jamia Millia Islamia. Stored cells were revived and cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 IU/mL), and streptomycin (100 µg/mL) in a humidified atmosphere at 5% CO2 at 37 °C until confluent. Confluent cells were sub-cultured every three days at 70–80 percent confluence using a trypsin/EDTA solution.

2.8.1. MTT {3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide} Assay

The cytotoxicity of MPME was measured by an MTT assay following a standard protocol [17]. In brief, 1 × 104 cells/well in a 96-well plate were treated with successive dilutions of extract (1500, 750, 375, 187.5, 93.75, 46.87, and 23.43 µg/mL) in complete DMEM and incubated for 24 h. Following incubation at 37 °C, a further 20 µL of MTT solution (5 mg/mL) was poured into each well and incubated for three hours. After incubation, the supernatant was discarded from each well, and formazan crystals were solubilized with 100 μL of dimethyl sulfoxide (DMSO) added to solubilize formazan crystals. The absorbance was recorded at 570 nm. The following equation was used to calculate data from three different experiments.
Cell viability (%) = (OD sample value)/(OD cell control) × 100.

2.8.2. Measurement of Glucose-Uptake

Cells were cultured in 12-well plates and incubated for 24 h, at 37 °C in a CO2 incubator. After 24 h, the media was discarded, and cells were washed with PBS. Cells were treated with MPME in serum-free DMEM containing 0.2% BSA and incubated for a further 24 h at 37 °C in a CO2 incubator. Glucose uptake in test samples and controls was measured in the spent media using a kit (Eton Bioscience, SKU-1200032002) as per the manufacturer’s instructions.

2.8.3. Detection of ROS in HepG2 Cells by Flow Cytometry Using 2′,7′-Dichlorodihydrofluorescein Diacetate (DCFDA)

The redox-sensitive fluorescence probe carboxy-2′,7′-dichlorodihydrofluorescein di-acetate carboxy-H2DCFDA; was used to estimate ROS production as per a previously reported method [18]. Briefly, HepG2 cells (2 × 105) were grown in 6-well plates and treated with different concentrations (23.43, 46.87, and 93.75 µg/mL) of MPME-containing media for 24. Media was removed, and cells were washed with PBS before inducing oxidative stress using 100 μM H2O2 for 1 h. The cells were trypsinized, 10 μM DCFH-DA was added to the culture media, and cells were incubated in the dark for 30 min. After incubation, the cells were washed with serum-free media to remove the unbound dye, followed by re-suspending the cells in PBS to measure ROS employing flow cytometry (BD FACS Aria III, USA) with an excitation wavelength of 485 nm and an emission wavelength of 525 nm.

2.8.4. Assessment of Apoptosis and Necrosis

HepG2 cells grown in 6-well plates were incubated with DMEM media with or without high glucose (HG) (50 mM) for 24 h at 37 °C. After incubation, MPME at varying concentrations was added to respective wells. After incubation, the extract was removed and cells were washed with PBS and 25 µL (1 × 105) of HepG2 cells were stained in a microcentrifuge tube with 5 µL of AO-EtBr (acridine orange (AO, 50 μg/mL) a green-fluorescent dye and ethidium bromide (EtBr, 100 μg/mL) a red fluorescent dye, for 15 min at 37 °C and placed in the dark with gentle mixing. A volume of 10 µL of cell suspension was mounted on a glass slide, covered with a glass coverslip, and examined with a fluorescence microscope with a fluorescein filter. Dual staining was visualized under a fluorescent microscope (Zoe fluorescent cell imager Bio-Rad, USA) with excitation at 488 nm and 550 nm [19].

2.8.5. Morphological Changes in HepG2 Cells

To visualize morphological changes in HepG2 cell nuclei, the cells were stained with DAPI and PI dyes and visualized using a fluorescence/confocal microscope.

Fluorescence Microscopy

Propidium iodide is a red fluorescent dye, only permeable when the cell structure is destabilized. It passes through the cell nucleus, intercalates between the bases of DNA, and shows fluorescence with an excitation/emission-maxima ~535/617 nm. The cells were incubated with or without HG (50 mM) and then treated with MPME (93.75 μg/mL) in selected wells. After incubation at 37 °C, the cells were washed with PBS and stained with PI (2.5 ng/μg) solution and incubated in the dark for 15 min at 25 °C [20]. The cells were visualized under a fluorescent microscope (Zoe fluorescent cell imager, Bio-Rad, USA) using a TRITC filter. Images were taken at 20× magnification.

Confocal Microscopy

Briefly, the HepG2 cells (1 × 106 cells/well) were seeded on 12-well plates [21]. After a 24-h pre-incubation period with or without glucose (50 mM), MPME (93.75 μg/mL) was added to selected wells. After 48 h of incubation at 37 °C, the cells were rinsed with PBS and fixed with 4% paraformaldehyde followed by 70% ethanol. The fixed cells were washed and stained with 100 μL (1 μg/mL) DAPI dye before being incubated at 37 °C for 30 min in a dark room. The unbound dye was then removed and 20 μL of PBS:glycerine (1:1) was added to the cells. Apoptotic cells, characterized by morphological changes in apoptotic nuclei, were observed using confocal microscopy (TCS SPS, Leica, Germany).

2.9. Statistical Analysis

Graph Pad Prism software Version 5.01 was used for statistical analysis. Comparison between groups was performed using Student’s t-test or one-way ANOVA and Tukey’s multiple comparison tests. Difference were considered statistically significant at p ˂ 0.05.

3. Results

3.1. Physicochemical Analysis

The outcomes of physicochemical tests were obtained within the allowed limits (Table S1). The percentage yield of the MPME extract was 11.125 ± 0.95% (w/w). The moisture content percentage was 1.25%. Low moisture content helped to increase the shelf life of MPME.

3.2. Total Phenolic and Flavonoid Content of the Extract

Using a gallic acid standard calibration curve (y = 0.0049x + 0.0597: R = 0.9969), the total phenolic content of the MPME was determined and was expressed as milligram equivalents of gallic acid per gram of dry extract (mg GAE/g). The total phenolic content was 157.3 ± 10.219 mg GAE/g of MPME (n = 3). The total flavonoid content was expressed using a standard calibration curve of rutin (y = 0.0052x + 0.0049: R = 0.9921) and the result was expressed as milligram equivalents of Rutin per gram of dry extract. The MPME contained a total flavonoid content of 78.121 ± 3.190 mg rutin/g of MPME (n = 3). Pterocarpus species are rich in phytoconstituents, including flavonoids, phenolic compounds, and terpenoids [22]. The high phenolic content of this plant is associated with significant health-promoting effects.

3.3. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis

The GC–MS chromatogram of MPME showed a total of 10 major peaks representing active compounds that were identified by peak retention time, peak area (%), height (%), and spectral fragmentation patterns of their mass to that of known compounds described by the National Institute of Standards and Technology (NIST) library (Figure S1). The tentatively recognized phytoconstituents are given in Table 1. Many antidiabetic constituents were identified such as myristic acid (18.095 Rt and 0.80% peak area), succinic acid (10.153 Rtand 0.76% peak area), (18.095 Rtand 0.80% peak area), isoeugenol (14.691 Rt and 0.80% peak area), pentadecanoic acid (19.658 Rt and 0.36% peak area), oleic Acid (30.449 Rtand 0.19% peak area), citronellal (20.361 Rtand 0.36% peak area), pentatriacontane (19.846 Rtand 0.02% peak area), and 14b-pregnane (24.064 Rtand 0.02% peak area)

3.4. HPTLC Fingerprinting and Quantitative Analysis

The current study showed many major and minor metabolites indicated by their retention factors (Table S2). The validation analysis for Quercetin was shown to be linear, precise, and consistent at a concentration range of 200–4000 ng/spot. For standard Quercetin, the calibration equation and coefficient were determined to be 1.066 + 458.5, and 0.993, respectively. For Quercetin, the limits of detection (LOD) and quantitation (LOQ) were found to be 13.65, and 41.39 ng/spot, respectively. Intra-day and inter-day precision were calculated as percent (%) relative standard deviation or the coefficient of variation, with values ranging from 0.44–0.79 and 1.44–1.66. The percentage of drug recovery was 99.21–102.66% (Table S3). In addition, the concentration of Quercetin in MPME was determined and found to be 0.409 ± 1.34 mg/g of the sample. Figure 1 shows chromatograms of the TLC plate at various wavelengths. Active constituents present in MPME may contribute to the robust antioxidant and antidiabetic activity of the plant.

3.5. Ultra-Performance Liquid Chromatography-Mass Spectroscopy (UPLC-MS) Studies

Metabolic profiling of MPME was determined using ultra-performance liquid chromatography-mass spectroscopy. MPME yielded a total of 29 major metabolites, (Table 2). The study was performed in a positive mode to identify the metabolites present in MPME. A chromatogram of the analysis is shown in Figure S2. The presence of major anti-diabetic bioactive compounds detected using UPLC-MS-based metabolite profiling included epicatechin (Rt 3.047), kaempferol-7-O-alpha-L-rhamnoside (Rt 3.047), curcumol (Rt 4.000), quercetin (Rt 4.000), iso-liquiritigenin (Rt 4.000), trans-pterostilbene (Rt 4.00), berberine (Rt 4.00), pinocembrin (Rt 4.000), formononetin (Rt 4.374), and amygdalin (Rt 6.519).

3.6. Studies Using the HepG2 Cell Line

3.6.1. Cytotoxic Effect of MPME on HepG2 Cell Line

The evaluation of cytotoxicity is regarded as a crucial step in estimating potential for the use of phytochemicals as drugs [23]. The MTT cell viability assay, which depends on the mitochondrial metabolic activity of viable cells, was used to investigate MPME on an HepG2 cell line with an MPME from a concentration of 1500 μg/mL to 23.43 μg/mL. The results of cell viability were revealed after 24 h of incubation of HepG2 cells with MPME, (Figure 2B). Higher concentrations (1500 μg/mL–750 μg/mL) of MPME-treated cells showed altered morphology, decrease in cell number, and shrinkage. The control cells were well attached and exhibited normal morphology (Figure 2A).

3.6.2. Glucose Uptake Assay

The effects of different concentrations (1500 µg/mL–23.43 µg/mL) of MPME on cell viability were investigated. Cell viability was initially evaluated to identify a safe dose with low cell cytotoxicity. This was further used to determine a safe dosage for the glucose uptake assay in HepG2 cells. A concentration of 96.75 μg/mL of MPME revealed significant cell viability, and this concentration of MPME was used for the analysis of glucose uptake in HepG2 cells. Excessive yellowing media was linked with high glucose utilization, and significant glucose uptake was observed in metformin-treated (positive control) cells. A significant increase in the glucose uptake by HepG2 cells was also observed after treatment with MPME (93.75 µg/mL) in comparison with the normal control (Figure 2C).

3.6.3. Detection of ROS in H2O2 Induced HepG2 Cells Using 2′,7′-Dichlorodihydrofluorescein Diacetate (DCFDA) Probe by Flow Cytometry

Measurement of ROS production is a clear sign of free radical-induced cell damage observed by non-fluorescent dye DCFH-DA. The ability of MPME to rescue H2O2-induced ROS production in HepG2 cells was quantified by measuring the fluorescence intensity of reacting DCFH and oxidative substrates. The fluorescent intensity of induced cells significantly increased when compared to untreated control cells. MPME (23.43, 46.87, and 93.75 μg/mL) retained high cell viability, and when added to H2O2-induced HepG2 cells, a significant reduction in fluorescent intensity was observed in a dose-dependent manner compared to untreated (control) cells (Figure 3).

3.6.4. Assessment of Apoptosis and Necrosis by Fluorescence Microscopy

HepG2 cells labeled with AO/EB after incubation in high glucose (HG) media showed much less apoptosis after treatment with MPME (93.75 μg/mL), and a significant protective effect of MPME was observed (Figure 4e). Late-stage apoptotic cells were seen with dense and abnormally localized orange nuclear EB labeling in untreated and HG-induced HepG2 cells (Figure 4b). The frequency of early-stage apoptotic and necrotic cells increased with a decrease in concentration (46.87 and 23.43 μg/mL) of MPME in HG-induced cells (Figure 4c,d). Untreated and induced cells as control showed healthy cells with the least apoptosis (Figure 4a). It was observed that MPME reduced late apoptosis and necrosis of HG-induced HepG2 cells in a concentration-dependent manner.

3.6.5. Assessment of Cellular Morphology on High Glucose (50 mM)-Induced HepG2 Cells

HG-induced oxidative stress caused cell damage and apoptosis in HepG2 cells, as observed by DAPI (4′,6-diamidino-2-phenylindole) and PI (Propidium iodide). It was observed that MPME (93.75 μg/mL) treatment reduced cell damage and apoptosis in HG-induced HepG2 cells when compared with untreated and HG-induced cells with different degrees of nuclear fragmentation and chromatin condensation, after PI staining as indicated by yellow arrows (Figure 5A–C). DAPI staining was performed to observe the protective effect of MPME (93.75 μg/mL) in high glucose-induced oxidative stress in HepG2 cells. The apoptotic cells appeared bright white, deformed, and florescent, while the normal viable cells appeared deep blue and evenly distributed and with uniform shape with DAPI staining (Figure 5E–G).

4. Discussion

Diabetes mellitus is one of the primary causes of mortality worldwide, and its prevalence is expected to increase in the coming decades. Studies have shown that diabetics are more susceptible to certain infectious illnesses, including COVID-19, resulting in serious complications [24]. Intensive research is going on to control and treat diabetes by targeting glucose upregulation, antioxidant activity, β cell regeneration, and several other combined mechanisms [25].
In this study, the methanolic heartwood extract of Pterocarpus marsupium (MPME) was found to have high phenolic and flavonoid content and is expected to play significant therapeutic roles. In this study, we identified many known antidiabetic saturated and unsaturated fatty acids, alcohols, and sterols such as myristic acid, succinic acid, isoeugenol, linolic acid, and citronellal, in MPME. Isoeugenol has been reported to activate AMP-activated protein kinase (AMPK) and improved glucose uptake in rat L6 myotubes [26]. Succinic acid has been used in insulin secretagogues, and its prolonged use improved pancreatic beta cell functioning [23]. The presence of these compounds in MPME may improve its antidiabetic potential. HPTLC is a linear, precise, and accurate approach for identifying herbal constituents [27]. The mobile phase showed sharp and defined peaks seen at different Rf values, at wavelengths of 245 nm and 366 nm, revealing the presence of various plant metabolites. MPME also had a significant amount of Quercetin, at 254 nm.
The presence of Quercetin in PM, using LC-MS analysis, has been reported earlier [28]. The robust antidiabetic property of Quercetin has also been reported [29]. The presence of Quercetin in MPME may promote its strong antidiabetic potential by decreasing oxyradicals and by enhancing antioxidant enzyme activity. Furthermore, diverse polar and nonpolar metabolites were present as identified using UPLC-MS.UPLC-MS analysis of MPME, which identified the presence of various potent antidiabetic and antioxidant metabolites such as epicatechin (Rt 3.047), quercetin (Rt 4.000), curcumol (Rt 4.000), trans-pterostilbene (Rt 4.000), and formononetin (Rt 4.374). Epicatechin (Rt 3.047) is a monomeric flavan-3-ol that is recognized for its antioxidant properties against free radicals. It has been isolated from the bark of P. marsupium and was shown to play a functional role in reducing oxidative and antidiabetic complications in both in vitro and in vivo studies [30]. Curcumol (Rt 4.000) has been shown to reduce acute and subchronic hyperglycemia [31]. Quercetin (Rt 4.000) is a flavonoid in the bark of P. marsupium and has also been reported in berries and citrus fruits. Quercetin is known for its antioxidant activity and has been shown to alleviate diabetes in rats [32]. Formononetin (Rt 4.374) is an O-methylated isoflavone and has already been identified in plants [28].
Formononetin has antioxidant properties and has been shown to attenuate kidney damage in type-2 diabetic rats [33]. Trans-pterostilbene (Rt 4.000) is a methoxybenzene and a diether, and has been shown to have an anti-diabetic effect via the PI3K/Akt signaling pathway in diabetic rats [33]. The presence of these antioxidant and antidiabetic compound in MPME may be the basis for its therapeutic properties, since it is rich in phytoconstituents including flavonoids [34], phenolic compounds, and terpenoids [22]. Recent studies have confirmed the major role of free radicles in life-threatening diseases including cancer and diabetes [35]. A HepG2 cell model was previously used to study the effects of various drugs on hyperglycemia [36]. In the present study, the antidiabetic property of MPME was investigated on HepG2 cells, and this study of MPME is the first report on its used with the HepG2 cell line. An MTT-based standard method was used to assess the cytotoxicity of MPME on the HepG2 cell line, and HepG2 cells were treated with different concentrations of MPME. Interestingly MPME was less toxic to the HepG2 cell line, which retained more than 75% cell viability at a concentration <100 μg mL. The concentration at which the MPME caused a 50% reduction in cells viability (IC50) was 552 μg/mL, which concurs with the previous experiments that reported moderate toxicity of the plant extract on other cancer cell lines, such as HeLa and A549 [37]. MPME showed less toxicity to HepG2 cells, while other species of the same genus, showed high toxicity to other cancer cell lines. For example, a methanolic extract of P. santalinus showed high toxicity to HeLa cells with an IC50 value of 40 μg/mL. Moreover, the bioactive compounds of P. santalinus also showed high toxicity on HepG2 cells [38].
Based on these results, <100 μg/mL concentrations of MPME were selected as a safe dose for conducting further experiments. Induction of glucose uptake and insulin-mimetic ability has been shown by many medicinal plants. This was attributed to the presence of various phytoconstituents that help in reducing blood glucose levels and alleviating diabetic complications [39]. The HepG2 cell line was earlier used as a model to study glucose uptake measurements [40]. In previous studies, it was reported that phytoconstituent from heartwood extract of MPME improved glucose uptake in different cell models [41]. The reason for high glucose uptake in the presence of MPME was attributed to the high content of phenolic compounds, tannins, and flavonoids present in MPME, as reported earlier [40]. MPME was previously reported to increase glucose uptake up to three-fold in MCF-7 cells [42]. The possible mechanism of glucose uptake by MPME-treated cells may be the engagement of antidiabetic phytoconstituents with a protein factor that may be involved in the insulin-mediated glucose transport signaling pathway, resulting in glucose uptake activation.
Glucose uptake is regulated by the activation of AMP-activated protein kinase (AMPK) via an insulin-independent mechanism. AMPK, and Protein kinase B (Akt) phosphorylation is supposed to be activated by the high phenolic content [43,44]. Flavonoids present in the extract may also be responsible for the increase in glucose uptake [43]. The current work, which employed the HepG2 cell model, aspired to study the protective capability of MPME from oxidative stress that leads to toxicity in the liver. Hyperglycemia leads to the production of reactive oxygen species (ROS), thereby resulting in DNA damage and causing apoptosis. MPME treatment may enhance the activities of antioxidant enzymes and significantly reduce intracellular ROS in induced HepG2 cells.. Previous studies have reported an increase in oxidative enzymes after treatment with heartwood extract of P. marsupium in MCF-7 cells [42].
A previous study reported that Pterostilbene, one of the major constituents of MPME, protects hippocampus neuronal cells from induced oxidative damage [45]. The ROS scavenging potential of MPME removes free radicles that cause cell damage, and this potential of MPME may help diabetic patients reduce diabetic complications. High glucose concentrations (HG) (50 mM) have been utilized to investigate hyperglycemia-induced oxidative damage in numerous tissues, as well as to precisely mimic the in vivo diabetic ketoacidosis observed in patients with acute or uncontrolled diabetes [46]. HepG2 cells undergo oxidative stress in the HG environment and show greater frequency of cell damage and apoptosis [47]. The current study investigated the therapeutic potential of MPME in a high glucose environment. Dual (AO/EB) staining showed an increased level of late apoptosis and necrosis due to increased oxidative stress in HG (50 mM)-induced cells. Different treatments with MPME showed a significant dose-dependent protective effect with low apoptosis in comparison to the negative control. It should be noted that necrosis is caused by cell injury due to high oxidative stress. Therefore, MPME works by rescuing cells from glucose-induced oxidative stress. Cell damage was evident in glucose-induced HepG2 cells with compromised cell membranes that allowed propidium iodide (PI) dye to bind within the nucleus. MPME-treated cells showed significantly less damage in comparison to the negative control.
The protective effect from HG-induced HepG2 cells offered by PMEM was also confirmed by DAPI nuclear staining. It was observed that HG-induced oxidative stress damaged the nucleus of HepG2 cells, and the healing effect of MPME in HG-induced cells was observed after DAPI staining by confocal microscopy. The literature suggests a rise in ROS production in induced HepG2 cells as one of the possible causes of cell membrane degradation and nucleus disintegration. Our results show the protective effect of MPME in HG-induced oxidative stress in HepG2 cells. The presence of various, identified antioxidant phytoconstituents, and their quenching potential, might be responsible for oxyradical detoxification and protecting cells from oxidative damage. A schematic representation of the possible mechanism of antidiabetic and cellular antioxidant activity offered by bioactive compounds identified by high-throughput analysis of MPME is shown in Figure 6.
From the present study, PM used as a traditional folk medicine is a potential hepatoprotective, shows ROS scavenging activity, and alleviates HG-induced toxicity via its antioxidant activities and high glucose uptake. The phytochemicals found in MPME may have an efficacious and protective effect against diabetes, which could be linked to both direct and indirect effects. MPME may help patients with comorbidities and exposure to pathogenic viruses such as SARS-CoV-2 that causes COVID-19. Furthermore, natural and herbal medicines have very less side effects and are therefore safer as well as being more effective in a holistic medicine. The metabolites identified in MPME have future potential as antidiabetic herbal drugs. Further exploration of the mechanism of action at the level of diabetes control would be of great therapeutic interest.

5. Conclusions

The present study detected and identified more than 20 antidiabetic compounds from MPME using UP-LCMS and GCMS analysis. The antidiabetic and antioxidant compound Quercetin was estimated quantitatively by HPTLC and its presence may contribute to the therapeutic potential of MPME. This study demonstrated the antidiabetic potential of MPME. The possible mechanism seems to be via sensitizing HepG2 cells towards glucose uptake. Cellular ROS scavenging activity showed by MPME in HepG2 cells may be due to an increase in the activity of the enzymes responsible for antioxidant potential, thereby inhibiting cellular damage and cell death. The study also demonstrated the hepatoprotective ability of MPME against high glucose (50 mM). The therapeutic potential for rescuing cells from high glucose-induced apoptosis may result from its high antioxidative activity. The active compounds in MPME act as natural remedies for diabetes treatment. However, further studies are required for isolating the active compounds and testing them in animal models of diabetes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo12100947/s1. Figure S1: GCMS chromatogram of MPME. Figure S2: UPLC-MS chromatogram of MPME. Table S1: Physiochemical parameters of MPME. Table S2: HPTLC fingerprint of MPME at 254 nm and 366 nm. Table S3: Linear regression data for calibration plots of the analyzed marker using the proposed HPTLC method.

Author Contributions

Conceptualization, M.I.D., K.D., S.A. (Sayeed Ahmad) and M.I.Q.; data curation, M.I.D. and S.R.; formal analysis, M.I.D., S.R., S.A. (Sageer Abass), M.U.K., W.A.A., S.S.M., S.A. (Sayeed Ahmad) and M.I.Q.; investigation, K.D., S.A. (Sayeed Ahmad) and M.I.Q.; methodology, M.I.D., S.R., S.A. (Sageer Abass), W.A.A. and S.S.M.; project administration, M.I.Q.; resources, K.D., S.A. (Sayeed Ahmad) and M.I.Q.; software, S.R., S.A. (Sageer Abass), M.U.K., W.A.A. and S.S.M.; supervision, S.A. (Sayeed Ahmad); validation, M.I.D., K.D., M.U.K. and S.S.M.; writing—original draft, M.I.D., W.A.A. and S.A (Sayeed Ahmad); writing—review & editing, M.I.Q. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and supplementary materials.

Acknowledgments

Acknowledgements are due to the Deanship of Scientific Research (DSR) at King Abdulaziz University (KAU), Jeddah, Saudi Arabia for funding through grant no. (RG-4-166-43) to Walaa A. Abualsunun.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. American Diabetes Association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care 2013, 36 (Suppl. 1), S67–S74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. International Diabetes Federation. IDF Diabetes Atlas, 9th ed.; International Diabetes Federation: Brussels, Belgium, 2019; ISBN 9782930229874. [Google Scholar]
  3. Khan, M.A.B.; Hashim, M.J.; King, J.K.; Govender, R.D.; Mustafa, H.; Kaabi, J. Al Epidemiology of type 2 Diabetes—Global burden of disease and forecasted trends. J. Epidemiol. Glob. Health 2020, 10, 107–111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Rizvi, S.I.; Srivastava, N. Erythrocyte plasma membrane redox system in first degree relatives of type 2 diabetic patients. Int. J. Diabetes Mellit. 2010, 2, 119–121. [Google Scholar] [CrossRef] [Green Version]
  5. Robertson, A.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in Diabetes. J. Biol. Chem. 2004, 279, 42351–42354. [Google Scholar] [CrossRef] [Green Version]
  6. Parhar, G.; Kalaji, W.; Sargi, J.; Adarkwah, O.; Zaman, K.; Gerolemou, L. A case of erythematous and vesicular rash in a critically ill patient admitted with Sars-CoV2: Viral or multi-drug effect? Chest 2020, 158, A719. [Google Scholar] [CrossRef]
  7. Gondi, M.; Prasada Rao, U.J.S. Ethanol extract of mango (Mangifera Indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats. J. Food Sci. Technol. 2015, 52, 7883–7893. [Google Scholar] [CrossRef] [Green Version]
  8. Balbi, M.E.; Tonin, F.S.; Mendes, A.M.; Borba, H.H.; Wiens, A.; Fernandez-Llimos, F.; Pontarolo, R. Antioxidant effects of vitamins in type 2 Diabetes: A meta-analysis of randomized controlled trials. Diabetol. Metab. Syndr. 2018, 10, 18. [Google Scholar] [CrossRef] [PubMed]
  9. Lee, J.; Noh, S.; Lim, S.; Kim, B. Plant extracts for Type 2 Diabetes: From traditional medicine to modern drug discovery. Antioxidants 2021, 10, 81. [Google Scholar] [CrossRef]
  10. Dhanabal, S.P.; Kokate, C.K.; Ramanathan, M.; Kumar, E.P.; Suresh, B. Hypoglycaemic activity of Pterocarpus marsupium Roxb. Phytother. Res. 2006, 20, 4–8. [Google Scholar] [CrossRef]
  11. Sheehan, E.W.; Zemaitis, M.A.; Slatkin, D.J.; Schiff, P.L. A constituent of Pterocarpus marsupium, (-)-epicatechin, as a potential antidiabetic agent. J. Nat. Prod. 1983, 46, 232–234. [Google Scholar] [CrossRef] [PubMed]
  12. Ip. Indian Pharmacopoeia. Appendix 9.4; Controller of Publication: Delhi, India, 1996. [Google Scholar]
  13. Khan, W.; Parveen, R.; Chester, K.; Parveen, S.; Ahmad, S. Hypoglycemic potential of aqueous extract of Moringa oleifera Leaf and in vivo GC-MS metabolomics. Front. Pharmacol. 2017, 8, 577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Saeed, N.; Khan, M.R.; Shabbir, M. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complement. Altern. Med. 2012, 12, 221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Zahiruddin, S.; Khan, W.; Nehra, R.; Alam, M.J.; Mallick, M.N.; Parveen, R.; Ahmad, S. Pharmacokinetics and comparative metabolic profiling of iridoid enriched fraction of Picrorhiza kurroa—An ayurvedic herb. J. Ethnopharmacol. 2017, 197, 157–164. [Google Scholar] [CrossRef] [PubMed]
  16. Rab, R.A.; Zahiruddin, S.; Ibrahim, M.; Husain, F.; Parveen, R.; Khan, W.; Ahmad, F.J.; Khan, A.A.; Ahmad, S. HPTLC and UPLC-MS/MS methods for quality control analysis of itrifal formulations of unani system of medicine. J. AOAC Int. 2021, 103, 649–658. [Google Scholar] [CrossRef]
  17. Zhao, S.; Zhang, L.; Xu, Z.H.; Chen, W.Q. Neurotoxic effects of iron overload under high glucose concentration. Neural Regen. Res. 2013, 8, 3423–3433. [Google Scholar] [CrossRef]
  18. Ding, Y.; Zhang, Z.; Yue, Z.; Ding, L.; Zhou, Y.; Huang, Z.; Huang, H. Rosmarinic acid ameliorates H2O2-induced oxidative stress in L02 cells through MAPK and Nrf2 pathways. Rejuvenation Res. 2019, 22, 289–298. [Google Scholar] [CrossRef]
  19. Venkatachalapathy, D.; Shivamallu, C.; Prasad, S.K.; Saradha, G.T.; Rudrapathy, P.; Amachawadi, R.G.; Patil, S.S.; Syed, A.; Elgorban, A.M.; Bahkali, A.H.; et al. Assessment of chemopreventive potential of the plant extracts against liver cancer using Hepg2 cell line. Molecules 2021, 26, 4593. [Google Scholar] [CrossRef]
  20. Brana, C.; Benham, C.; Sundstrom, L. A Method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res. Protoc. 2002, 10, 109–114. [Google Scholar] [CrossRef]
  21. Machana, S.; Weerapreeyakul, N.; Barusrux, S.; Nonpunya, A.; Sripanidkulchai, B.; Thitimetharoch, T. Cytotoxic and apoptotic effects of six herbal plants against the human hepatocarcinoma (HepG2) cell line. Chin. Med. 2011, 6, 39. [Google Scholar] [CrossRef] [Green Version]
  22. Arbain, D.; Saputri, G.A.; Syahputra, G.S.; Widiyastuti, Y.; Susanti, D.; Taher, M. Genus Pterocarpus: A review of ethnopharmacology, phytochemistry, biological activities, and clinical evidence. J. Ethnopharmacol. 2021, 278, 114316. [Google Scholar] [CrossRef]
  23. Picton, S.F.; Flatt, P.R.; McClenaghan, N.H. Differential acute and long term actions of succinic acid monomethyl ester exposure on insulin-secreting BRIN-BD11 cells. Int. J. Exp. Diabetes Res. 2001, 2, 19–27. [Google Scholar] [CrossRef] [Green Version]
  24. Guo, W.; Li, M.; Dong, Y.; Zhou, H.; Zhang, Z.; Tian, C.; Qin, R.; Wang, H.; Shen, Y.; Du, K.; et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes/Metab. Res. Rev. 2020, 36, e3319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Kapoor, M.; Kaur, G.; Kaur, N.; Sharma, C.; Batra, K.; Singh, D. The traditional uses, phytochemistry and pharmacology of genus Hibiscus: A review. Eur. J. Med. Plants 2021, 32, 1–37. [Google Scholar] [CrossRef]
  26. Kim, N.; Lee, J.O.; Lee, H.J.; Lee, Y.W.; Kim, H.I.; Kim, S.J.; Park, S.H.; Lee, C.S.; Ryoo, S.W.; Hwang, G.S.; et al. AMPK, a metabolic sensor, is involved in isoeugenol-induced glucose uptake in muscle cells. J. Endocrinol. 2016, 228, 105–114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Romero Rocamora, C.; Ramasamy, K.; Meng Lim, S.; Majeed, A.B.A.; Agatonovic-Kustrin, S. HPTLC based approach for bioassay-guided evaluation of antidiabetic and neuroprotective effects of eight essential oils of the Lamiaceae family plants. J. Pharm. Biomed. Anal. 2020, 178, 112909. [Google Scholar] [CrossRef] [PubMed]
  28. Singh, P.; Bajpai, V.; Gupta, A.; Gaikwad, A.N.; Maurya, R.; Kumar, B. Identification and quantification of secondary metabolites of Pterocarpus marsupium by LC–MS techniques and its in-vitro lipid lowering activity. Ind. Crops Prod. 2019, 127, 26–35. [Google Scholar] [CrossRef]
  29. Bule, M.; Abdurahman, A.; Nikfar, S.; Abdollahi, M.; Amini, M. Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies. Food Chem. Toxicol. 2019, 125, 494–502. [Google Scholar] [CrossRef]
  30. Kim, M.J.; Ryu, G.R.; Chung, J.S.; Sim, S.S.; Min, D.S.; Rhie, D.J.; Yoon, S.H.; Hahn, S.J.; Kim, M.S.; Jo, Y.H. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: In Vivo and in vitro. Pancreas 2003, 26, 292–299. [Google Scholar] [CrossRef]
  31. Raafat, K.M.; Omar, A.G. Phytotherapeutic activity of curcumol: Isolation, GC–MS identification, and assessing potentials against acute and subchronic hyperglycemia, tactile allodynia, and hyperalgesia. Pharm. Biol. 2016, 54, 1334–1344. [Google Scholar] [CrossRef]
  32. Yang, D.K.; Kang, H.S. Anti-diabetic effect of cotreatment with quercetin and resveratrol in streptozotocin-induced diabetic rats. Biomol. Ther. 2018, 26, 130–138. [Google Scholar] [CrossRef]
  33. Oza, M.J.; Kulkarni, Y.A. Formononetin attenuates kidney damage in type 2 diabetic rats. Life Sci. 2019, 219, 109–121. [Google Scholar] [CrossRef] [PubMed]
  34. Mitra, J.; Joshi, T. Isoflavonoids from the heartwood of Pterocarpus marsupium. Phytochemistry 1983, 22, 2326–2327. [Google Scholar] [CrossRef]
  35. Devasagayam, T.P.A.; Tilak, J.C.; Boloor, K.K.; Sane, K.S.; Ghaskadbi, S.S.; Lele, R.D. Free radicals and antioxidants in human health: Current status and future prospects. J. Assoc. Physicians India 2004, 52, 794–804. [Google Scholar] [PubMed]
  36. Bourebaba, N.; Kornicka-Garbowska, K.; Marycz, K.; Bourebaba, L.; Kowalczuk, A. Laurus nobilis ethanolic extract attenuates hyperglycemia and hyperinsulinemia-induced insulin resistance in HepG2 Cell line through the reduction of oxidative stress and improvement of mitochondrial biogenesis—Possible implication in pharmacotherapy. Mitochondrion 2021, 59, 190–213. [Google Scholar] [CrossRef] [PubMed]
  37. Gulati, V.; Gulati, P.; Harding, I.H.; Palombo, E.A. Exploring the anti-diabetic potential of australian aboriginal and indian ayurvedic plant extracts using cell-based assays. BMC Complement. Altern. Med. 2015, 15, 8. [Google Scholar] [CrossRef] [Green Version]
  38. Wu, S.F.; Hwang, T.L.; Chen, S.L.; Wu, C.C.; Ohkoshi, E.; Lee, K.H.; Chang, F.R.; Wu, Y.C. Bioactive components from the heartwood of Pterocarpus santalinus. Bioorganic Med. Chem. Lett. 2011, 21, 5630–5632. [Google Scholar] [CrossRef]
  39. Choudhury, H.; Pandey, M.; Hua, C.K.; Mun, C.S.; Jing, J.K.; Kong, L.; Ern, L.Y.; Ashraf, N.A.; Kit, S.W.; Yee, T.S.; et al. An update on natural compounds in the remedy of Diabetes Mellitus: A systematic review. J. Tradit. Complement. Med. 2018, 8, 361–376. [Google Scholar] [CrossRef]
  40. Ho, G.T.T.; Yen Nguyen, T.K.; Kase, E.T.; Tadesse, M.; Barsett, H.; Wangensteen, H. Enhanced glucose uptake in human liver cells and inhibition of carbohydrate hydrolyzing enzymes by Nordic berry extracts. Molecules 2017, 22, 1806. [Google Scholar] [CrossRef] [Green Version]
  41. Mishra, A.; Srivastava, R.; Srivastava, S.P.; Gautam, S.; Tamrakar, A.K.; Maurya, R.; Srivastava, A.K. Antidiabetic activity of heart wood of Pterocarpus marsupium Roxb. and analysis of phytoconstituents. Indian J. Exp. Biol. 2013, 51, 363–374. [Google Scholar]
  42. Dabur, R. Identification of molecular pathways affected by treatment with heartwood water extract of Pterocarpus marsupium in MCF 7 cancer cell line. J. Herb. Med. 2017, 9, 42–52. [Google Scholar] [CrossRef]
  43. Mihaylova, M.M.; Shaw, R.J. The AMP-activated protein kinase (AMPK) signaling pathway coordinates cell growth, autophagy, & metabolism. Nat. Cell Biol. 2011, 13, 1016–1023. [Google Scholar]
  44. Rabanal-Ruiz, Y.; Otten, E.G.; Korolchuk, V.I. MTORC1 as the main gateway to autophagy. Essays Biochem. 2017, 61, 565–584. [Google Scholar]
  45. Yang, Y.; Fan, C.; Wang, B.; Ma, Z.; Wang, D.; Gong, B.; Di, S.; Jiang, S.; Li, Y.; Li, T.; et al. Pterostilbene attenuates high glucose-induced oxidative injury in hippocampal neuronal cells by activating nuclear factor erythroid 2-related factor 2. Biochim. Et Biophys. Acta Mol. Basis Dis. 2017, 1863, 827–837. [Google Scholar] [CrossRef]
  46. Pitocco, D.; Tesauro, M.; Alessandro, R.; Ghirlanda, G.; Cardillo, C. Oxidative stress in Diabetes: Implications for vascular and other complications. Int. J. Mol. Sci. 2013, 14, 21525–21550. [Google Scholar] [CrossRef] [Green Version]
  47. Chandrasekaran, K.; Swaminathan, K.; Chatterjee, S.; Dey, A. Apoptosis in HepG2 cells exposed to high glucose. Toxicol. In Vitro 2010, 24, 387–396. [Google Scholar] [CrossRef]
  48. Maradagi, T.; Kumar, R.; Ponesakki, G. Hyperglycaemia-induced human hepatocellular carcinoma (HepG2) cell proliferation through ROS-mediated P38 activation is effectively inhibited by a xanthophyll carotenoid, lutein. Diabet. Med. 2022, 39, e14713. [Google Scholar] [CrossRef]
  49. Das, B.K.; Knott, R.M.; Gadad, P.C. Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway. Future J. Pharm. Sci. 2021, 7, 43. [Google Scholar] [CrossRef]
Figure 1. High-performance thin-layer chromatography (HPTLC) chromatoplate of methanolic heartwood extract of Pterocarpus marsupium (MPME) (V1-V2) and Quercetin (S1–S12) under 254 nm (A) and at 366 nm (B). HPTLC chromatogram of MPME scanned at UV 254 nm (C), HPTLC chromatogram of Quercetin scanned at UV 254 nm (D), and HPTLC chromatogram of MPME scanned at UV 366 nm (E).
Figure 1. High-performance thin-layer chromatography (HPTLC) chromatoplate of methanolic heartwood extract of Pterocarpus marsupium (MPME) (V1-V2) and Quercetin (S1–S12) under 254 nm (A) and at 366 nm (B). HPTLC chromatogram of MPME scanned at UV 254 nm (C), HPTLC chromatogram of Quercetin scanned at UV 254 nm (D), and HPTLC chromatogram of MPME scanned at UV 366 nm (E).
Metabolites 12 00947 g001
Figure 2. (A) Morphological changes in HepG2 cells after MPME treatment for 24 h. Untreated (Control) (a), Methanolic heartwood extract of Pterocarpus marsupium (MPME) (1500 µg/mL) (b), MPME (750 µg/mL) (c), MPME (375 µg/mL) (d), MPME (187.5 µg/mL) (e), MPME (93.75 µg/mL) (f), MPME (46.87 µg/mL) (g), MPME (23.43 µg/mL) (h). (B) Effect of MPME on HepG2 cell viability analyzed by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) assay. Cells were exposed to increasing concentrations of MPME from 1500 µg/mL to 23.43 µg/mL for 24 h. Data are represented as means [±] standard deviation (SD) (n = 3). The asterisks (*) indicate statistical significant differences with the control (* p < 0.05, ** p < 0.01, *** p < 0.001, ns p ˃ 0.5). (C) Effect of MPME (93.75 µg/mL) on glucose uptake in HepG2 cells for 24 h. Data were analyzed by unpaired, two-tailed, t-test and presented as (±) standard error of mean (SEM) (n = 3) with significance * p < 0.05, *** p < 0.001 compared to untreated control.
Figure 2. (A) Morphological changes in HepG2 cells after MPME treatment for 24 h. Untreated (Control) (a), Methanolic heartwood extract of Pterocarpus marsupium (MPME) (1500 µg/mL) (b), MPME (750 µg/mL) (c), MPME (375 µg/mL) (d), MPME (187.5 µg/mL) (e), MPME (93.75 µg/mL) (f), MPME (46.87 µg/mL) (g), MPME (23.43 µg/mL) (h). (B) Effect of MPME on HepG2 cell viability analyzed by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) assay. Cells were exposed to increasing concentrations of MPME from 1500 µg/mL to 23.43 µg/mL for 24 h. Data are represented as means [±] standard deviation (SD) (n = 3). The asterisks (*) indicate statistical significant differences with the control (* p < 0.05, ** p < 0.01, *** p < 0.001, ns p ˃ 0.5). (C) Effect of MPME (93.75 µg/mL) on glucose uptake in HepG2 cells for 24 h. Data were analyzed by unpaired, two-tailed, t-test and presented as (±) standard error of mean (SEM) (n = 3) with significance * p < 0.05, *** p < 0.001 compared to untreated control.
Metabolites 12 00947 g002
Figure 3. Flow cytometry analysis of intracellular reactive oxygen species (ROS) by H2O2-induced HepG2 cells, quantified by DCFH-DA probe. (A) Fluorescent intensity (ROS) of untreated and unstimulated HepG2 cells (control) was 3.8% (a) H2O2 induced cells was 30.1% (b) H2O2 induced cells + 23.43 µg/mL MPME was 20.5% (c) H2O2 induced cells + 46.87 µg/mL MPME was 17.2% (d) H2O2 induced cells + 93.75 µg/mL MPME was 15.5% (e) respectively. (B) Relative intensity fold of DCFDA staining. The asterisks (*) indicate statistical significant differences with the control (** p < 0.01, *** p < 0.001). + and − indicate the presence and absence of MPME/H2O2-100 μM (C) Fluorescence microscopy images (20×) of MPME stained with DCFDA to visualize ROS accumulation. In MPME treatments for 24 h, a decline in ROS generation compared to H2O2 stimulated cells was observed.
Figure 3. Flow cytometry analysis of intracellular reactive oxygen species (ROS) by H2O2-induced HepG2 cells, quantified by DCFH-DA probe. (A) Fluorescent intensity (ROS) of untreated and unstimulated HepG2 cells (control) was 3.8% (a) H2O2 induced cells was 30.1% (b) H2O2 induced cells + 23.43 µg/mL MPME was 20.5% (c) H2O2 induced cells + 46.87 µg/mL MPME was 17.2% (d) H2O2 induced cells + 93.75 µg/mL MPME was 15.5% (e) respectively. (B) Relative intensity fold of DCFDA staining. The asterisks (*) indicate statistical significant differences with the control (** p < 0.01, *** p < 0.001). + and − indicate the presence and absence of MPME/H2O2-100 μM (C) Fluorescence microscopy images (20×) of MPME stained with DCFDA to visualize ROS accumulation. In MPME treatments for 24 h, a decline in ROS generation compared to H2O2 stimulated cells was observed.
Metabolites 12 00947 g003
Figure 4. Effect of methanolic heartwood extract of Pterocarpus marsupium (MPME) on high glucose HG (50 mM)-induced apoptosis in HepG2 cells with acridine orange (AO)/EtBr staining. Fluorescence observation of HepG2 cells (unstimulated and untreated). Control (a); HG (50 mM) (b); High glucose (HG) + 23.43 µg/mL (c); HG + 46.87 µg/mL MPME (d); HG cells + 93.75 µg/mL MPME; (e) treated cells, with dual staining (AO (100 μg/mL): EtBr (100 μg/mL)) was in a 1:1 ratio. + and − indicate the presence and absence of MPME/HG (50mM). The HepG2 cells were examined under a fluorescence microscope in three different channels (green, red, and merged) with 20× magnification. The green nucleus of viable cells and the blood-red nucleus of apoptotic cells showed the morphological alterations of apoptosis following 24 h of drug treatment.
Figure 4. Effect of methanolic heartwood extract of Pterocarpus marsupium (MPME) on high glucose HG (50 mM)-induced apoptosis in HepG2 cells with acridine orange (AO)/EtBr staining. Fluorescence observation of HepG2 cells (unstimulated and untreated). Control (a); HG (50 mM) (b); High glucose (HG) + 23.43 µg/mL (c); HG + 46.87 µg/mL MPME (d); HG cells + 93.75 µg/mL MPME; (e) treated cells, with dual staining (AO (100 μg/mL): EtBr (100 μg/mL)) was in a 1:1 ratio. + and − indicate the presence and absence of MPME/HG (50mM). The HepG2 cells were examined under a fluorescence microscope in three different channels (green, red, and merged) with 20× magnification. The green nucleus of viable cells and the blood-red nucleus of apoptotic cells showed the morphological alterations of apoptosis following 24 h of drug treatment.
Metabolites 12 00947 g004
Figure 5. PI is a membrane-impermeant dye and stains only dead cells. Treatment of methanolic heartwood extract of Pterocarpus marsupium (MPME) 93.75 µg/mL for 24 h rescued the high glucose (HG)-induced HepG2 cells from apoptosis. PI stanning: normal control (A); HG (50 mM) (B); HG + 93.75 µg/mL MPME (C). Cell morphology was observed under a fluorescence microscope with 20× magnification. Yellow arrows signify the apoptotic cells. Fluorescence intensity after PI staining is represented by a bar diagram (D). Data are expressed as unpaired one-tailed t-test and are presented as the mean intensity of PI-stained cells. The asterisks (*) indicate statistical significant differences with the control (** p < 0.01, *** p < 0.001). DAPI Staining: confocal microscopic study untreated (control) (E); HG (50 mM) (F); HG + 93.75 µg/mL MPME (G). Cell morphology was observed under a confocal microscope at 40× magnification. Yellow arrows indicate apoptotic cells.
Figure 5. PI is a membrane-impermeant dye and stains only dead cells. Treatment of methanolic heartwood extract of Pterocarpus marsupium (MPME) 93.75 µg/mL for 24 h rescued the high glucose (HG)-induced HepG2 cells from apoptosis. PI stanning: normal control (A); HG (50 mM) (B); HG + 93.75 µg/mL MPME (C). Cell morphology was observed under a fluorescence microscope with 20× magnification. Yellow arrows signify the apoptotic cells. Fluorescence intensity after PI staining is represented by a bar diagram (D). Data are expressed as unpaired one-tailed t-test and are presented as the mean intensity of PI-stained cells. The asterisks (*) indicate statistical significant differences with the control (** p < 0.01, *** p < 0.001). DAPI Staining: confocal microscopic study untreated (control) (E); HG (50 mM) (F); HG + 93.75 µg/mL MPME (G). Cell morphology was observed under a confocal microscope at 40× magnification. Yellow arrows indicate apoptotic cells.
Metabolites 12 00947 g005
Figure 6. Schematic representation of the mechanism of potential antidiabetic and cellular antioxidant activities conferred by bioactive compounds such as epicatechin, quercetin, isoliquiritigenin, and formononetin identified by UPLC-MS and HPTLC analysis from a heartwood extract of Pterocarpus marsupium. The identified bioactive compounds relieve oxidative stress and attenuate apoptosis by regulation of ROS in a high glucose, H2O2-induced environment in HepG2 cells [48,49].
Figure 6. Schematic representation of the mechanism of potential antidiabetic and cellular antioxidant activities conferred by bioactive compounds such as epicatechin, quercetin, isoliquiritigenin, and formononetin identified by UPLC-MS and HPTLC analysis from a heartwood extract of Pterocarpus marsupium. The identified bioactive compounds relieve oxidative stress and attenuate apoptosis by regulation of ROS in a high glucose, H2O2-induced environment in HepG2 cells [48,49].
Metabolites 12 00947 g006
Table 1. Phytocompounds identified in MPME by GC-MS analysis.
Table 1. Phytocompounds identified in MPME by GC-MS analysis.
RTCompoundMolecular Formula Mol Weight g·mol−1Peak Area
8.832BenzaldehydeC7H6O106.1219.92
10.153Succinic acid C5H8O410.1530.76
11.120Ethyl hydrogen succinateC6H10O4146.140.20
11.933CyclohexaneC6H1284.160.11
14.3885-DimethoxybenzaldehydeC9H10O3166.170.98
14.691IsoeugenolC10H12O2164.2040.41
15.0912,4-bis (1,1-dimethylethylC17H3OSi278.515.89
15.669Penta-fluoropropionic acidC3HF5O2164.031.66
15.9442′,5′-DimethoxypropiophenoneC11H14O3194.230.04
16.722DocosaneC22H46310.60.12
17.701CyclopentaneC5H1070.130.32
18.095Myristic acidC14H28O22280.80
18.307Oleyl alcoholC18H36O268.50.03
18.7483,5-Dimethoxybenzyl alcoholC9H12O3168.192.62
19.4631,2-Benzenedicarboxylic acidC24H38O43900.20
19.658Pentadecanoic acidC15H30O2242.4030.36
19.846PentatriacontaneC35H72492.90.02
20.361CitronellalC10H18O154.250.09
20.693IsotridecanolC13H28O200.360.10
21.374Dibutyl phthalateC16H22O4278 1.21
21.394Phthalic acid (1,2-Benzenedicarboxylic acid)C8H6O4166.131.21
21.820Hexadecanoic acidC16H32O225621.55
22.736Oxiranepentanoic acidC5H10O2102.130.06
24.06414b-pregnaneC21H36288.50.02
24.207Heptadecanoic acidC17H34O2270.50.14
26.530Octadecanoic acidC18H36O228420.01
25.7929,12-Octadecadienoic acidC18H32O22800.33
30.449Oleic AcidC18H34O2282.470.19
Table 2. List of Phytoconstituents identified by ultra-performance liquid chromatography-mass spectroscopy(UP-LCMS) in methanolic heartwood extract of Pterocarpus marsupium.
Table 2. List of Phytoconstituents identified by ultra-performance liquid chromatography-mass spectroscopy(UP-LCMS) in methanolic heartwood extract of Pterocarpus marsupium.
RTTentative MassExact
Mass
PhytoconstituentFormulaClassMass Record
3.047179.0136178.187002-Methoxycinnamic acidC10H10O3Cinnamic acidMass Bank ID (MBID):PR305807
3.047291.1891290.27100 EpicatechinC15H14O6FlavonoidMBID:PS045605
3.047453.1309452.13190AspalathinC21H24O11FlavonoidMBID:BS003543
3.047463.2752462.07983 Kaempferol-3-GlucuronideC21H18O12FlavonoidMBID:PR101022
3.047417.0264416.4PterocarposideC21H20O9FlavonoidPub-Chm CID;01012651
3.047433.0309432.10565 Kaempferol-7-O-alpha-L-rhamnosideC21H20O10CoumarinsMBID:PR100942
3.047434.8582434.12131 Naringenin-7-O-glucosideC21H22O10FlavonoidMBID:BS003367
3.047437.2526436.13696 PhloridzinC21H24O10FlavonoidMBID:CE000071
3.047437.2526436.18860 ArtocaprinC26H28O6FlavonoidMBID:BS003597
4.000237.0566236.17763CurcumolC15H24O2SesquiterpenoidMBID:FIO01064
4.000257.0337256.25699 Iso-liquiritigeninC15H12O4HydroxychalconeMBID:PR302707
4.000257.0337256.07355 PinocembrinC15H12O4FlavonoidMBID:BML00869
4.000257.2227256.30099 Trans-pterostilbeneC16H16O3StilbenoidMBID:PR308326
4.000485.1395284.35550 DihydroartemisininC15H24O5SesquiterpeneMBID:NGA00138
4.000485.1395284.06848 WogoninC16H12O5FlavonoidMBID:TY000033
4.000285.1395284.03207 RheinC15H8O6Cassic acidMBID:BML01013
4.000485.1395284.06848 Biochanin AC16H12O5AnthraquinoneMBID:PN000109
4.000303.1256302.04226Quercetin C15H10O7FlavonoidMBID:PN000111
4.000337.2532336.12357 BerberineC20H18NOFlavonoidMBID:KO008886
4.000336.1189335.17331 SenecionineC18H25NO5AlkaloidMBID:NA002260
4.000352.2504351.16818RetrorsineC18H25NO6AlkaloidMBID:BML82062
4.374241.0898240.25MoscatinC15H12O3PhenolPub-Chm CID:194774
4.374269.1331268.26TectochrysinC16H12O4FlavonoidPub-Chm CID:5281954
4.374268.9441268.26FormononetinC16H12O4IsoflavonoidPub-Chm CID:5280378
4.374457.4785456.53900VindolineC25H32N2O6 Monoterpene indole alkaloidMBID:PM000601
6.519149.0768148.05243Citramalic acidC5H8O5Hydroxy-fatty acidMBID:PR100770
6.519240.0815239.094646-AminoflavanoneC15H13NO2FlavonoidMBID:JP000716
6.519458.0455457.15842 AmygdalinC20H27NO11Organooxygen compoundMBID:TY000092
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dar, M.I.; Rafat, S.; Dev, K.; Abass, S.; Khan, M.U.; Abualsunun, W.A.; Murshid, S.S.; Ahmad, S.; Qureshi, M.I. Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells. Metabolites 2022, 12, 947. https://doi.org/10.3390/metabo12100947

AMA Style

Dar MI, Rafat S, Dev K, Abass S, Khan MU, Abualsunun WA, Murshid SS, Ahmad S, Qureshi MI. Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells. Metabolites. 2022; 12(10):947. https://doi.org/10.3390/metabo12100947

Chicago/Turabian Style

Dar, Mohammad Irfan, Sahar Rafat, Kapil Dev, Sageer Abass, Mohammad Umar Khan, Walaa A. Abualsunun, Samar S. Murshid, Sayeed Ahmad, and Mohammad Irfan Qureshi. 2022. "Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells" Metabolites 12, no. 10: 947. https://doi.org/10.3390/metabo12100947

APA Style

Dar, M. I., Rafat, S., Dev, K., Abass, S., Khan, M. U., Abualsunun, W. A., Murshid, S. S., Ahmad, S., & Qureshi, M. I. (2022). Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells. Metabolites, 12(10), 947. https://doi.org/10.3390/metabo12100947

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop